Dual‐functional Nanosized Albumin Facilitates CRISPR‐Cas9‐PAR2 to Mitigate Cytokine Storm via TLR4 and Pyroptosis Signaling
Jianbin Li(Guangxi University), Yuhong Jiang(Southwest Jiaotong University)
Cited by 5
Related Papers
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells
|Journal of Pharmacology and Experimental Therapeutics|2017|66
Targeting PAR2 Overcomes Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells Through Inhibition of EGFR Transactivation
|Frontiers in Pharmacology|2021|24